MedPath
HSA Approval

NOPERTEN 5 TABLET 5 mg

SIN12005P

NOPERTEN 5 TABLET 5 mg

NOPERTEN 5 TABLET 5 mg

July 1, 2002

APOTHECA MARKETING PTE LTD

APOTHECA MARKETING PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantAPOTHECA MARKETING PTE LTD
Licence HolderAPOTHECA MARKETING PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

C09AA03

lisinopril

Manufacturer Information

APOTHECA MARKETING PTE LTD

PT DEXA MEDICA

Active Ingredients

LISINOPRIL

5 mg

Lisinopril

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

NOPERTEN 5 TABLET 5 mg - HSA Approval | MedPath